 Vesna Todorovic
Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesia, General | 13 | 2023 | 121 | 3.150 |
Why?
| | Calcium Channels, T-Type | 10 | 2017 | 104 | 2.990 |
Why?
| | Isoflurane | 6 | 2021 | 41 | 2.370 |
Why?
| | Anesthetics, General | 6 | 2023 | 14 | 1.910 |
Why?
| | Neurotoxicity Syndromes | 7 | 2017 | 40 | 1.660 |
Why?
| | Anesthetics | 6 | 2022 | 99 | 1.620 |
Why?
| | Brain | 18 | 2022 | 2934 | 1.590 |
Why?
| | Anesthetics, Inhalation | 6 | 2026 | 52 | 1.470 |
Why?
| | Calcium Channel Blockers | 5 | 2015 | 165 | 1.280 |
Why?
| | Sensory Receptor Cells | 5 | 2014 | 98 | 1.260 |
Why?
| | Hippocampus | 8 | 2026 | 966 | 1.110 |
Why?
| | Neuralgia | 5 | 2017 | 148 | 1.060 |
Why?
| | Child Development | 3 | 2018 | 482 | 1.000 |
Why?
| | Presynaptic Terminals | 3 | 2015 | 89 | 0.990 |
Why?
| | Analgesics | 3 | 2014 | 232 | 0.940 |
Why?
| | Diabetic Neuropathies | 3 | 2014 | 99 | 0.830 |
Why?
| | Ganglia, Spinal | 5 | 2017 | 89 | 0.800 |
Why?
| | Neuronal Plasticity | 5 | 2019 | 306 | 0.740 |
Why?
| | Hypnotics and Sedatives | 4 | 2017 | 216 | 0.730 |
Why?
| | Animals | 46 | 2026 | 37948 | 0.730 |
Why?
| | Rats, Sprague-Dawley | 17 | 2019 | 2521 | 0.720 |
Why?
| | Neurons | 6 | 2016 | 1639 | 0.710 |
Why?
| | Neuroprotection | 1 | 2021 | 45 | 0.690 |
Why?
| | Hyperalgesia | 4 | 2017 | 132 | 0.680 |
Why?
| | Anesthesia, Inhalation | 2 | 2015 | 14 | 0.680 |
Why?
| | Rats | 21 | 2018 | 5570 | 0.680 |
Why?
| | Pain | 3 | 2017 | 785 | 0.670 |
Why?
| | Synaptic Vesicles | 2 | 2015 | 40 | 0.660 |
Why?
| | tau Proteins | 1 | 2022 | 115 | 0.650 |
Why?
| | Synaptic Transmission | 4 | 2022 | 292 | 0.650 |
Why?
| | Synapses | 5 | 2026 | 437 | 0.640 |
Why?
| | Propofol | 5 | 2017 | 85 | 0.640 |
Why?
| | Child Behavior | 2 | 2013 | 236 | 0.630 |
Why?
| | Anesthesia | 3 | 2017 | 258 | 0.630 |
Why?
| | Benzamides | 2 | 2018 | 224 | 0.600 |
Why?
| | Neuroprotective Agents | 2 | 2014 | 145 | 0.550 |
Why?
| | Inhibitory Postsynaptic Potentials | 2 | 2015 | 47 | 0.540 |
Why?
| | Testosterone | 1 | 2022 | 412 | 0.530 |
Why?
| | Macaca | 1 | 2017 | 65 | 0.520 |
Why?
| | Animals, Newborn | 12 | 2026 | 890 | 0.510 |
Why?
| | Peripheral Nerves | 2 | 2014 | 71 | 0.500 |
Why?
| | Action Potentials | 2 | 2017 | 502 | 0.490 |
Why?
| | Neural Inhibition | 1 | 2018 | 178 | 0.490 |
Why?
| | Models, Animal | 1 | 2018 | 393 | 0.480 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2018 | 218 | 0.470 |
Why?
| | Thalamus | 2 | 2015 | 127 | 0.470 |
Why?
| | Axons | 2 | 2018 | 203 | 0.460 |
Why?
| | Ventral Thalamic Nuclei | 1 | 2015 | 5 | 0.450 |
Why?
| | Gasotransmitters | 1 | 2014 | 2 | 0.420 |
Why?
| | Autism Spectrum Disorder | 2 | 2026 | 410 | 0.420 |
Why?
| | Carbon Monoxide | 1 | 2014 | 82 | 0.410 |
Why?
| | Pregnanolone | 1 | 2014 | 34 | 0.400 |
Why?
| | Cognition Disorders | 6 | 2019 | 539 | 0.400 |
Why?
| | Pyridines | 1 | 2018 | 603 | 0.390 |
Why?
| | Neural Pathways | 1 | 2015 | 311 | 0.380 |
Why?
| | Nociception | 1 | 2013 | 17 | 0.380 |
Why?
| | Glycosylation | 1 | 2013 | 161 | 0.380 |
Why?
| | Calcium Channels | 1 | 2013 | 155 | 0.370 |
Why?
| | Oxidation-Reduction | 2 | 2013 | 1078 | 0.370 |
Why?
| | Cerebral Cortex | 2 | 2015 | 470 | 0.360 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 464 | 0.350 |
Why?
| | Nitrous Oxide | 2 | 2015 | 35 | 0.330 |
Why?
| | Drug Delivery Systems | 1 | 2014 | 380 | 0.320 |
Why?
| | Neuropeptides | 3 | 2017 | 74 | 0.310 |
Why?
| | Neuroglia | 2 | 2016 | 173 | 0.310 |
Why?
| | Nociceptors | 3 | 2014 | 40 | 0.300 |
Why?
| | Patch-Clamp Techniques | 3 | 2015 | 289 | 0.290 |
Why?
| | Ketamine | 2 | 2022 | 133 | 0.290 |
Why?
| | Sciatic Neuropathy | 2 | 2015 | 33 | 0.290 |
Why?
| | Cognition | 2 | 2021 | 1263 | 0.280 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 423 | 0.280 |
Why?
| | Mice | 11 | 2026 | 18261 | 0.280 |
Why?
| | Anesthesiology | 2 | 2017 | 178 | 0.280 |
Why?
| | Methyl Ethers | 2 | 2026 | 19 | 0.270 |
Why?
| | Rats, Wistar | 6 | 2017 | 449 | 0.270 |
Why?
| | Microscopy, Electron | 3 | 2015 | 413 | 0.250 |
Why?
| | Radiculopathy | 1 | 2017 | 37 | 0.250 |
Why?
| | Anesthetics, Intravenous | 3 | 2016 | 69 | 0.250 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2017 | 33 | 0.250 |
Why?
| | Primates | 2 | 2021 | 133 | 0.250 |
Why?
| | Connexins | 1 | 2017 | 54 | 0.240 |
Why?
| | Fas Ligand Protein | 1 | 2016 | 60 | 0.240 |
Why?
| | Pregnanediones | 1 | 2026 | 12 | 0.240 |
Why?
| | fas Receptor | 1 | 2016 | 92 | 0.230 |
Why?
| | Nerve Tissue Proteins | 3 | 2017 | 590 | 0.230 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 168 | 0.230 |
Why?
| | Cytoskeleton | 2 | 2011 | 197 | 0.230 |
Why?
| | Inflammasomes | 1 | 2017 | 145 | 0.230 |
Why?
| | Nerve Degeneration | 2 | 2015 | 48 | 0.220 |
Why?
| | Benzothiazoles | 2 | 2013 | 39 | 0.210 |
Why?
| | Phosphorylation | 3 | 2022 | 1704 | 0.210 |
Why?
| | Mice, Inbred C57BL | 5 | 2026 | 5967 | 0.200 |
Why?
| | Male | 18 | 2026 | 72431 | 0.200 |
Why?
| | Up-Regulation | 3 | 2019 | 848 | 0.190 |
Why?
| | Mitochondrial Dynamics | 1 | 2013 | 40 | 0.190 |
Why?
| | Social Behavior | 2 | 2026 | 287 | 0.190 |
Why?
| | Midazolam | 3 | 2015 | 72 | 0.190 |
Why?
| | Muscimol | 1 | 2011 | 23 | 0.180 |
Why?
| | Myelin Proteins | 1 | 2011 | 45 | 0.180 |
Why?
| | Infant | 5 | 2018 | 10023 | 0.170 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 40 | 0.170 |
Why?
| | Female | 14 | 2022 | 78304 | 0.160 |
Why?
| | Nanoparticles | 1 | 2017 | 512 | 0.160 |
Why?
| | Humans | 18 | 2023 | 144667 | 0.160 |
Why?
| | Periodicals as Topic | 1 | 2013 | 206 | 0.160 |
Why?
| | Mice, Knockout | 3 | 2017 | 3109 | 0.160 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 143 | 0.160 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2016 | 151 | 0.160 |
Why?
| | Drug Synergism | 2 | 2015 | 352 | 0.160 |
Why?
| | Behavior, Animal | 2 | 2014 | 521 | 0.160 |
Why?
| | Biological Transport | 2 | 2015 | 418 | 0.150 |
Why?
| | Genes, Immediate-Early | 1 | 2019 | 26 | 0.150 |
Why?
| | Child, Preschool | 4 | 2018 | 11790 | 0.150 |
Why?
| | Astrocytes | 1 | 2011 | 228 | 0.140 |
Why?
| | Actins | 1 | 2011 | 421 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2016 | 194 | 0.140 |
Why?
| | Mitochondria | 3 | 2013 | 984 | 0.140 |
Why?
| | Anesthetics, Dissociative | 1 | 2018 | 46 | 0.130 |
Why?
| | Organ Culture Techniques | 1 | 2018 | 149 | 0.130 |
Why?
| | Apoptosis | 1 | 2016 | 2397 | 0.130 |
Why?
| | Antioxidants | 3 | 2013 | 546 | 0.130 |
Why?
| | Cell Membrane | 2 | 2015 | 706 | 0.130 |
Why?
| | Stereotyped Behavior | 1 | 2017 | 22 | 0.130 |
Why?
| | Nerve Growth Factor | 2 | 2014 | 34 | 0.130 |
Why?
| | alpha-Synuclein | 1 | 2017 | 45 | 0.130 |
Why?
| | Memory | 1 | 2019 | 296 | 0.130 |
Why?
| | Dextroamphetamine | 1 | 2015 | 4 | 0.120 |
Why?
| | Hyperkinesis | 1 | 2015 | 16 | 0.120 |
Why?
| | Cell Death | 1 | 2017 | 382 | 0.120 |
Why?
| | Long-Term Potentiation | 1 | 2017 | 199 | 0.110 |
Why?
| | Pain Measurement | 2 | 2015 | 554 | 0.110 |
Why?
| | 4-Butyrolactone | 1 | 2015 | 23 | 0.110 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2015 | 39 | 0.110 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 9 | 0.110 |
Why?
| | Oncogene Protein v-akt | 1 | 2014 | 22 | 0.110 |
Why?
| | United Kingdom | 2 | 2017 | 337 | 0.110 |
Why?
| | Mibefradil | 1 | 2014 | 9 | 0.100 |
Why?
| | Neurogenesis | 2 | 2016 | 157 | 0.100 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2015 | 119 | 0.100 |
Why?
| | Receptors, GABA-A | 1 | 2015 | 137 | 0.100 |
Why?
| | Electric Stimulation | 1 | 2015 | 277 | 0.100 |
Why?
| | Thioctic Acid | 1 | 2013 | 12 | 0.100 |
Why?
| | Child | 4 | 2017 | 22600 | 0.100 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2013 | 9 | 0.100 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 185 | 0.100 |
Why?
| | Neuraminidase | 1 | 2013 | 25 | 0.100 |
Why?
| | Mice, Obese | 1 | 2013 | 66 | 0.100 |
Why?
| | Asparagine | 1 | 2013 | 34 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2018 | 6399 | 0.100 |
Why?
| | Piperidines | 1 | 2015 | 219 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2019 | 0.100 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1046 | 0.100 |
Why?
| | Sciatic Nerve | 1 | 2013 | 63 | 0.100 |
Why?
| | Blotting, Western | 3 | 2013 | 1161 | 0.090 |
Why?
| | Nerve Fibers | 1 | 2013 | 105 | 0.090 |
Why?
| | Catalysis | 1 | 2013 | 319 | 0.090 |
Why?
| | Metals | 1 | 2013 | 139 | 0.090 |
Why?
| | Cysteine | 1 | 2013 | 207 | 0.090 |
Why?
| | Protein Isoforms | 1 | 2013 | 396 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2012 | 78 | 0.090 |
Why?
| | GTP Phosphohydrolases | 2 | 2013 | 93 | 0.090 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2011 | 9 | 0.090 |
Why?
| | Posterior Horn Cells | 1 | 2011 | 10 | 0.090 |
Why?
| | Inhibitory Concentration 50 | 1 | 2011 | 90 | 0.090 |
Why?
| | Epigenesis, Genetic | 1 | 2016 | 669 | 0.080 |
Why?
| | Arachidonic Acid | 1 | 2011 | 101 | 0.080 |
Why?
| | Antibodies | 1 | 2013 | 396 | 0.080 |
Why?
| | Transfection | 1 | 2013 | 924 | 0.080 |
Why?
| | Macaca mulatta | 1 | 2011 | 186 | 0.080 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 70 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2013 | 4110 | 0.080 |
Why?
| | Ion Channel Gating | 1 | 2011 | 93 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2013 | 743 | 0.080 |
Why?
| | Morphogenesis | 1 | 2011 | 172 | 0.080 |
Why?
| | Child Behavior Disorders | 1 | 2012 | 118 | 0.080 |
Why?
| | Histones | 1 | 2016 | 663 | 0.080 |
Why?
| | GTP-Binding Proteins | 1 | 2011 | 153 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 507 | 0.080 |
Why?
| | Epilepsy | 1 | 2015 | 386 | 0.080 |
Why?
| | Intellectual Disability | 1 | 2012 | 174 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1363 | 0.080 |
Why?
| | Environment | 1 | 2011 | 306 | 0.080 |
Why?
| | Caspase 3 | 2 | 2026 | 234 | 0.080 |
Why?
| | Signal Transduction | 2 | 2014 | 5185 | 0.070 |
Why?
| | Anxiety | 1 | 2017 | 1122 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1207 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1705 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2013 | 894 | 0.070 |
Why?
| | Maze Learning | 2 | 2013 | 105 | 0.070 |
Why?
| | Skin | 1 | 2013 | 762 | 0.070 |
Why?
| | Molecular Targeted Therapy | 1 | 2011 | 437 | 0.070 |
Why?
| | Base Sequence | 1 | 2011 | 2177 | 0.070 |
Why?
| | Time Factors | 4 | 2017 | 7140 | 0.070 |
Why?
| | Calcium | 1 | 2013 | 1182 | 0.060 |
Why?
| | Motor Activity | 2 | 2017 | 723 | 0.060 |
Why?
| | Diabetic Nephropathies | 1 | 2011 | 318 | 0.060 |
Why?
| | Age Factors | 2 | 2012 | 3329 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2016 | 2815 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2015 | 1301 | 0.060 |
Why?
| | Caspase 8 | 1 | 2016 | 47 | 0.060 |
Why?
| | Caspase 9 | 1 | 2016 | 51 | 0.060 |
Why?
| | Neuroimmunomodulation | 1 | 2016 | 68 | 0.060 |
Why?
| | Caspase 1 | 1 | 2016 | 146 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 321 | 0.060 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 601 | 0.060 |
Why?
| | Adjuvants, Anesthesia | 1 | 2015 | 13 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2017 | 372 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 238 | 0.050 |
Why?
| | Emergency Medical Services | 1 | 2011 | 695 | 0.050 |
Why?
| | Exploratory Behavior | 2 | 2017 | 85 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2016 | 390 | 0.050 |
Why?
| | Microglia | 1 | 2016 | 269 | 0.050 |
Why?
| | Austria | 1 | 2013 | 8 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2013 | 73 | 0.050 |
Why?
| | Dynamins | 1 | 2013 | 36 | 0.050 |
Why?
| | Pediatrics | 1 | 2011 | 1121 | 0.050 |
Why?
| | Catalase | 1 | 2013 | 133 | 0.050 |
Why?
| | Mossy Fibers, Hippocampal | 1 | 2022 | 12 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2013 | 195 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2026 | 452 | 0.050 |
Why?
| | Cytoplasm | 1 | 2013 | 257 | 0.050 |
Why?
| | GABA-A Receptor Agonists | 1 | 2011 | 17 | 0.040 |
Why?
| | Gene Expression | 1 | 2017 | 1476 | 0.040 |
Why?
| | Memory Disorders | 1 | 2013 | 196 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2014 | 2950 | 0.040 |
Why?
| | Paxillin | 1 | 2011 | 11 | 0.040 |
Why?
| | Myosin Light Chains | 1 | 2011 | 26 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 906 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 303 | 0.040 |
Why?
| | Vimentin | 1 | 2011 | 54 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 262 | 0.040 |
Why?
| | Immunoprecipitation | 1 | 2011 | 147 | 0.040 |
Why?
| | Down-Regulation | 1 | 2013 | 616 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 125 | 0.040 |
Why?
| | Cell Division | 1 | 2011 | 753 | 0.040 |
Why?
| | Homeostasis | 1 | 2013 | 639 | 0.040 |
Why?
| | Dendritic Spines | 1 | 2019 | 69 | 0.040 |
Why?
| | Pregnancy | 1 | 2012 | 7122 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2014 | 11735 | 0.040 |
Why?
| | Adaptation, Ocular | 1 | 2017 | 6 | 0.030 |
Why?
| | Synaptophysin | 1 | 2017 | 15 | 0.030 |
Why?
| | Risk Factors | 1 | 2012 | 10796 | 0.030 |
Why?
| | Sex Factors | 1 | 2013 | 2104 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2013 | 1159 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4539 | 0.030 |
Why?
| | GAP-43 Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 195 | 0.030 |
Why?
| | Nipecotic Acids | 1 | 2015 | 6 | 0.030 |
Why?
| | GABA Antagonists | 1 | 2015 | 34 | 0.030 |
Why?
| | Oximes | 1 | 2015 | 26 | 0.030 |
Why?
| | Cadherins | 1 | 2017 | 200 | 0.030 |
Why?
| | Learning | 1 | 2019 | 448 | 0.030 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2014 | 18 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 2014 | 53 | 0.030 |
Why?
| | Streptozocin | 1 | 2014 | 22 | 0.030 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2014 | 185 | 0.020 |
Why?
| | Receptor, trkB | 1 | 2012 | 39 | 0.020 |
Why?
| | Salicylates | 1 | 2011 | 29 | 0.020 |
Why?
| | Dinoprost | 1 | 2011 | 49 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 163 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 174 | 0.020 |
Why?
| | Hypothalamus | 1 | 2012 | 160 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2012 | 287 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2011 | 113 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8284 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 779 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 435 | 0.020 |
Why?
| | Oxygen | 1 | 2011 | 984 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2591 | 0.010 |
Why?
| | Aged | 1 | 2013 | 25955 | 0.010 |
Why?
|
|
Todorovic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|